The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53

被引:77
作者
Gobert, C
Skladanowski, A
Larsen, AK
机构
[1] CNRS, Lab Biol & Pharmacol DNA Topoisomerases, UMR 8532, Inst Gustave Roussy, F-94805 Villejuif, France
[2] Gdansk Tech Univ, Dept Pharmaceut Technol & Biochem, PL-80952 Gdansk, Poland
关键词
D O I
10.1073/pnas.96.18.10355
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
DNA topoisomerase I is a nuclear enzyme involved in transcription, recombination, and DNA damage recognition. Previous studies have shown that topoisomerase I interacts directly with the tumor-suppressor protein p53, p53 is a transcription factor that activates certain genes through binding to specific DNA sequences, We now report that topoisomerase I can be stimulated by both latent and activated wild-type p53 as well as by several mutant and truncated p53 proteins in vitro, indicating that sequence-specific DNA-binding and stimulation of topoisomerase I are distinct properties of p53, These assays also suggest that the binding site for topoisomerase I on p53 is between amino acids 302 and 321, In living cells, the interaction between p53 and topoisomerase I is strongly dependent on p53 status. In MCF-7 cells, which have wild-type p53, the association between the two proteins is tightly regulated in a spatial and temporal manner and takes place only during brief periods of genotoxic stress. In marked contrast, the two proteins are constitutively associated in HT-29 cells, which have mutant p53, These findings have important implications for both cellular stress response and genomic stability, given the ability of topoisomerase I to recognize DNA lesions as well as to cause illegitimate recombination.
引用
收藏
页码:10355 / 10360
页数:6
相关论文
共 46 条
[1]  
Albor A, 1998, CANCER RES, V58, P2091
[2]   MUTAGENICITY AND CARCINOGENICITY OF TOPOISOMERASE-INTERACTIVE AGENTS [J].
ANDERSON, RD ;
BERGER, NA .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1994, 309 (01) :109-142
[3]  
APPEL K, 1995, ONCOGENE, V11, P1971
[4]   CELL-CYCLE ANALYSIS OF AMOUNT AND DISTRIBUTION OF NUCLEAR-DNA TOPOISOMERASE-I AS DETERMINED BY FLUORESCENCE DIGITAL IMAGING MICROSCOPY [J].
BAKER, SD ;
WADKINS, RM ;
STEWART, CF ;
BECK, WT ;
DANKS, MK .
CYTOMETRY, 1995, 19 (02) :134-145
[5]   ASSOCIATION OF CROSSOVER POINTS WITH TOPOISOMERASE-I CLEAVAGE SITES - A MODEL FOR NONHOMOLOGOUS RECOMBINATION [J].
BULLOCK, P ;
CHAMPOUX, JJ ;
BOTCHAN, M .
SCIENCE, 1985, 230 (4728) :954-958
[6]   Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases [J].
Cheng, CH ;
Kussie, P ;
Pavletich, N ;
Shuman, S .
CELL, 1998, 92 (06) :841-850
[7]  
CHRISTIANSEN K, 1994, J BIOL CHEM, V269, P721
[8]   MICROINJECTION OF ANTI-TOPOISOMERASE-I IMMUNOGLOBULIN-G INTO NUCLEI OF CHIRONOMUS-TENTANS SALIVARY-GLAND CELLS LEADS TO BLOCKAGE OF TRANSCRIPTION ELONGATION [J].
EGYHAZI, E ;
DURBAN, E .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (12) :4308-4316
[9]   DROSOPHILA DNA TOPOISOMERASE-I IS ASSOCIATED WITH TRANSCRIPTIONALLY ACTIVE REGIONS OF THE GENOME [J].
FLEISCHMANN, G ;
PFLUGFELDER, G ;
STEINER, EK ;
JAVAHERIAN, K ;
HOWARD, GC ;
WANG, JC ;
ELGIN, SCR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22) :6958-6962
[10]   Modulation of DNA topoisomerase I activity by p53 [J].
Gobert, C ;
Bracco, L ;
Rossi, F ;
Olivier, M ;
Tazi, J ;
Lavelle, F ;
Larsen, AK ;
Riou, JF .
BIOCHEMISTRY, 1996, 35 (18) :5778-5786